US cardiology market price
2023
US $16.67 billion
2030
US $25.60 billion
CAGR (compound annual growth rate)
6.32%
(2024-2030)
Cardiovascular disease (CVD)
#1 reason for death in the U.S.
Market increasers
Upward growth in cardiovascular sickness due to:
- Weight problems
- High blood pressure
- Diabetes
Technology advancements
Minimally invasive methods
Imagining techniques
Material advancements
Wearables
Remote monitoring
Benefits of technology advancements
Enhance patient results
Lessen healing times
Increase efficiency of cardiovascular treatments
Technology used ranges from echocardiography machines and stress tests to catheterization labs.
Key players in the cardiovascular market
Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences
Cardinal Health Inc.
Medtronic PLC
GE Healthcare
Johnson & Johnson Services, Inc.
Siemens Healthcare GmbH
https://www.researchandmarkets.com/report/united-states-cardiovascular-devices-market
ICONS: ADOBE STOCK
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Loading...
Explore the May 2024 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Stryker raises full-year guidance despite muted investor reaction
- Unlocking 3D vision: Basler AG launches Stereo ace camera series
- Lisa Anderson, supply chain & manufacturing expert, comments on the One Big Beautiful Act and its implications for US manufacturers
- Tooling and clamping solutions for optimum machining performance
- BGS US launches state-of-the-art E-Beam sterilization facility
- How suppliers can adapt to the shifting EV landscape
- AI will power the next generation of medical wearables
- CUI Crash Course from Smithers
